Rapport
Public health guidance on prevention and control of blood-borne viruses in prison settings. Prevention and control of communicable diseases in prison settings. Scientific advice
Auteur(s) :
OEDT = EMCDDA (Observatoire européen des drogues et des dépendances = European monitoring centre for drugs and drug addiction) ;
European Centre for Disease Prevention and Control (ECDC)
Année
2018
Page(s) :
68 p.
Langue(s) :
Anglais
Éditeur(s) :
Lisbon : OEDT / EMCDDA
;
Stockholm : ECDC (European Centre for Disease Prevention and Control)
Collection :
Joint publications
ISBN :
978-92-9498-194-3
Refs biblio. :
273
Domaine :
Drogues illicites / Illicit drugs
Discipline :
MAL (Maladies infectieuses / Infectious diseases)
Thésaurus mots-clés
PRISON
;
VIRUS
;
PREVENTION
;
PROGRAMME
;
HEPATITE
;
VIH
;
PRISE EN CHARGE
;
EFFICACITE
;
VACCINATION
;
TRAITEMENT
;
INJECTION
;
REDUCTION DES RISQUES ET DES DOMMAGES
;
INFECTION
Thésaurus géographique
EUROPE
;
UNION EUROPEENNE
Note générale :
Editorial: Active case finding for communicable diseases in prisons. The Lancet, 2018; 391(10136): p. 2186.
Résumé :
This evidence-based guidance aims to support the planning and implementation of effective programmes to prevent and control the transmission of infectious diseases in prison settings in the European region. It focuses on three high-burden blood-borne viruses (BBV) in the prison population, namely hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodefciency virus (HIV). The infections caused by these viruses are characterised by the same modes of blood-borne transmission and similar prevention and control interventions. The key areas covered by this guidance are prevention, treatment and care of BBVs in prison settings.
Historique